Paul Rubinstein, MD, is Associate Professor of Medicine in the Division of Hematology and Oncology at the University of Illinois College of Medicine Chicago, and he practices in the Division of Hematology/Oncology at UI Health. His clinical focus is on treating hematological malignancies, and his research interests focus on the mechanism of disease, treatment, and new therapies for HIV-/AIDS-associated hematological malignancies and non-HIV associated lymphomas. Since 2012, he has been involved with and authoring clinical trials with the aim of developing improved and novel therapies, understanding the biology mechanism of diseases and the epidemiology of cancer in people living with HIV/AIDS. He is also invovled in clinical research in hematologic malignancies in the non-HIV population. He is a member of the AIDS Malignancy Consortium, a clinical trials consortium funded by the National Cancer Institute (NCI), where he has authored multicenter international trials for both Hodgkin and non-Hodgkin lymphoma; currently, he is the only investigator in Illinois that has trials open for the treatment and prevention of HIV-/AIDS-associated malignancies. He is a member of the Big Ten Cancer Consortium and Alliance for Clinical Trials in Oncology, where his focus is to open clinical trials for the treatment of lymphomas.
Paul Rubinstein, MD
Associate Professor
Hematology and Oncology
Medicine
Research Program
Translational Oncology Program (TO)
Email: [email protected]
